Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial Intelligence.
Publication
, Journal Article
Lyman, G; Kuderer, N
Published in: Cancer Invest
February 2025
Duke Scholars
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
February 2025
Volume
43
Issue
2
Start / End Page
115 / 118
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G., & Kuderer, N. (2025). Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial Intelligence. Cancer Invest, 43(2), 115–118. https://doi.org/10.1080/07357907.2025.2467565
Lyman, Gary, and Nicole Kuderer. “Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial Intelligence.” Cancer Invest 43, no. 2 (February 2025): 115–18. https://doi.org/10.1080/07357907.2025.2467565.
Lyman G, Kuderer N. Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial Intelligence. Cancer Invest. 2025 Feb;43(2):115–8.
Lyman, Gary, and Nicole Kuderer. “Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial Intelligence.” Cancer Invest, vol. 43, no. 2, Feb. 2025, pp. 115–18. Pubmed, doi:10.1080/07357907.2025.2467565.
Lyman G, Kuderer N. Artificial Intelligence in Cancer Clinical Research: V. What We Have Learned About Human Intelligence from Artificial Intelligence. Cancer Invest. 2025 Feb;43(2):115–118.
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
February 2025
Volume
43
Issue
2
Start / End Page
115 / 118
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis